Yu Chang Selected Research

N- (2- (triphenylmethyl)thioethyl)- 3- aza- 19- ethyloxycarbonyl- 3- (2- (triphenylmethyl)thioethyl)octadecanoate

1/2014	High performance liquid chromatography-tandem mass spectrometry method for ex vivo metabolic studies of a rhenium-labeled radiopharmaceutical for liver cancer.
10/2011	Synthesis and application of 188Re-MN-16ET/Lipiodol in a hepatocellular carcinoma animal model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yu Chang Research Topics

Disease

45	Neoplasms (Cancer) 04/2024 - 01/2003
16	Lymphoma (Lymphomas) 01/2024 - 01/2014
9	Heart Failure 03/2023 - 09/2011
7	Prostatic Neoplasms (Prostate Cancer) 05/2024 - 01/2022
7	T-Cell Lymphoma (Lymphoma, T Cell) 04/2023 - 12/2015
6	Inflammation (Inflammations) 06/2024 - 01/2016
6	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 10/2011
6	Neoplasm Metastasis (Metastasis) 03/2024 - 11/2013
6	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 01/2015
5	Colorectal Neoplasms (Colorectal Cancer) 03/2024 - 01/2014
5	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2023 - 07/2013
4	Hemorrhage 05/2024 - 04/2009
4	Endometriosis 01/2021 - 02/2014
4	Body Weight (Weight, Body) 01/2020 - 11/2003
3	Carcinogenesis 06/2024 - 01/2018
3	Breast Neoplasms (Breast Cancer) 04/2024 - 11/2013
3	Hyperglycemia 01/2024 - 04/2017
3	Obesity 01/2024 - 04/2018
3	Stroke (Strokes) 07/2023 - 09/2013
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023 - 12/2014
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2022 - 01/2015
3	Colonic Neoplasms (Colon Cancer) 02/2021 - 04/2014
3	Liver Neoplasms (Liver Cancer) 01/2019 - 01/2014
2	Head and Neck Neoplasms (Head and Neck Cancer) 04/2024 - 01/2020
2	Pancreatic Neoplasms (Pancreatic Cancer) 04/2024 - 01/2013
2	Frailty 03/2024 - 03/2023
2	Lung Neoplasms (Lung Cancer) 02/2024 - 01/2019
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 02/2024 - 02/2024
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 07/2023
2	Hypertension (High Blood Pressure) 01/2024 - 02/2022
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2024 - 01/2024
2	Unconsciousness (Loss of Consciousness) 12/2023 - 01/2023
2	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 11/2023 - 10/2019
2	Disease Progression 10/2023 - 01/2022
2	Infections 10/2023 - 08/2023
2	Pain (Aches) 03/2023 - 01/2023
2	Anemia 03/2023 - 01/2018
2	Dizziness (Lightheadedness) 01/2023 - 01/2023
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2022 - 01/2020
2	Melanoma (Melanoma, Malignant) 12/2022 - 03/2014
2	Liver Diseases (Liver Disease) 12/2022 - 06/2022

Drug/Important Bio-Agent (IBA)

11	Cisplatin (Platino)FDA LinkGeneric 02/2024 - 11/2014
10	Biomarkers (Surrogate Marker)IBA 04/2024 - 07/2016
10	Dexamethasone (Maxidex)FDA LinkGeneric 02/2024 - 01/2014
10	Proteins (Proteins, Gene)FDA Link 01/2024 - 07/2013
8	Gemcitabine FDA Link 01/2022 - 11/2014
7	pegaspargase (Oncaspar)FDA Link 01/2022 - 11/2014
6	Transcription Factors (Transcription Factor)IBA 04/2024 - 01/2013
6	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2024 - 01/2017
5	Phosphotransferases (Kinase)IBA 03/2024 - 01/2016
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2024 - 01/2017
4	Adenosine Triphosphatases (ATPase)IBA 04/2024 - 01/2022
4	Androgen Receptors (Androgen Receptor)IBA 04/2024 - 01/2022
4	Proton Pump InhibitorsIBA 04/2024 - 01/2022
4	Vincristine (Oncovin)FDA LinkGeneric 02/2024 - 01/2017
4	Prednisone (Sone)FDA LinkGeneric 02/2024 - 01/2017
4	Cytarabine (Cytosar-U)FDA LinkGeneric 02/2024 - 01/2014
4	Etoposide (VP 16)FDA LinkGeneric 01/2023 - 01/2019
4	fotemustine (Muphoran)IBA 01/2023 - 01/2014
3	Adenosine Triphosphate (ATP)IBA 04/2024 - 12/2015
3	ChromatinIBA 04/2024 - 01/2022
3	enzalutamideIBA 04/2024 - 01/2022
3	Cyclin-Dependent Kinases (cdk Proteins)IBA 03/2024 - 01/2022
3	Rituximab (Mabthera)FDA Link 02/2024 - 01/2019
3	LipidsIBA 01/2024 - 06/2022
3	Methotrexate (Mexate)FDA LinkGeneric 04/2023 - 01/2014
3	CytokinesIBA 03/2023 - 11/2013
3	Thalidomide (Thalomid)FDA Link 01/2020 - 01/2017
3	Polysaccharides (Glycans)IBA 04/2018 - 04/2017
3	Messenger RNA (mRNA)IBA 07/2016 - 01/2013
2	snake venom protein C activatorIBA 04/2024 - 03/2024
2	Sucrose (Saccharose)IBA 04/2024 - 03/2024
2	palbociclibIBA 04/2024 - 10/2023
2	Immune Checkpoint InhibitorsIBA 03/2024 - 12/2022
2	Tyrosine Kinase InhibitorsIBA 02/2024 - 03/2018
2	Agammaglobulinaemia Tyrosine KinaseIBA 02/2024 - 02/2024
2	Immunoglobulin E (IgE)IBA 01/2024 - 10/2022
2	Anti-Allergic Agents (Antiallergic Agents)IBA 01/2024 - 10/2022
2	Uric Acid (Urate)IBA 01/2024 - 09/2013
2	Propofol (Diprivan)FDA LinkGeneric 12/2023 - 01/2023
2	ORALIT (ORS)IBA 07/2023 - 01/2023
2	ChemokinesIBA 03/2023 - 10/2022
2	MetalsIBA 01/2023 - 01/2023
2	Estrogens (Estrogen)FDA Link 06/2022 - 01/2021
2	ErbB Receptors (EGF Receptor)IBA 02/2022 - 03/2014
2	Asparaginase (Elspar)FDA Link 01/2022 - 01/2017
2	LipopolysaccharidesIBA 10/2021 - 03/2021

Therapy/Procedure

21	Therapeutics 04/2024 - 04/2009
17	Drug Therapy (Chemotherapy) 03/2024 - 12/2014
14	Radiotherapy 05/2024 - 05/2016
7	Heart-Assist Devices 12/2019 - 09/2011
5	Proton Therapy 05/2024 - 01/2019
4	Castration 04/2024 - 01/2022
3	Immunotherapy 12/2023 - 01/2022
3	Immunomodulation 04/2018 - 04/2017
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 10/2023 - 12/2019
2	Arthroplasty 08/2023 - 01/2023
2	Length of Stay 03/2023 - 09/2018
2	Extracorporeal Membrane Oxygenation 01/2023 - 04/2021
2	VAP-cyclo protocol 12/2021 - 01/2017